Hsp90 is a potential risk factor for ovarian cancer prognosis: an evidence of a Chinese clinical center.

Duan C, Li K, Pan X, Wei Z, Xiao L

Open source

DOI
10.1186/s12885-023-10929-9
Published
2023 May 31
Container
BMC cancer
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1186/s12885-023-10929-9,
  title = {Hsp90 is a potential risk factor for ovarian cancer prognosis: an evidence of a Chinese clinical center.},
  author = {Duan C and Li K and Pan X and Wei Z and Xiao L},
  year = {2023},
  journal = {BMC cancer},
  doi = {10.1186/s12885-023-10929-9},
  url = {https://doi.org/10.1186/s12885-023-10929-9}
}

RIS

TY  - JOUR
TI  - Hsp90 is a potential risk factor for ovarian cancer prognosis: an evidence of a Chinese clinical center.
AU  - Duan C
AU  - Li K
AU  - Pan X
AU  - Wei Z
AU  - Xiao L
PY  - 2023
JO  - BMC cancer
DO  - 10.1186/s12885-023-10929-9
UR  - https://doi.org/10.1186/s12885-023-10929-9
ER  - 

APA

C, D., K, L., X, P., Z, W., & L, X. (2023). Hsp90 is a potential risk factor for ovarian cancer prognosis: an evidence of a Chinese clinical center.. BMC cancer. https://doi.org/10.1186/s12885-023-10929-9

Source records